Subscribe to stay informed!
Malvern-based Endo International received court approval earlier this week for its reorganization plan, over 18 months after the company filed for Chapter 11 bankruptcy…
Endo International, the Ireland-based biopharmaceutical company with U.S. headquarters in Malvern, is on track to finally emerge from bankruptcy after reaching a deal…
Seven state attorneys general, including Pennsylvania AG Josh Shapiro, and a federal bankruptcy overseer appointed by the court, are objecting to the $94 million paid…
Endo International, with North American headquarters in Malvern, filed for bankruptcy last week, yet it has been revealed that $55.5 million in bonuses were…
Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, has announced plans to restructure the company and eliminate 560 jobs…
Malvern-based Endo Pharmaceuticals has agreed to acquire BioSpecifics Technologies, a 20-year-old company based in Wilmington, for around $658 million, writes Joseph DiStefano…
Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, has received marketing approval from the FDA for its injectable drug…
Endo International, the Dublin-based pharmaceutical company that has its U.S. headquarters in Malvern, has found its new CEO in Blaise Coleman. He is…
Before we send you to this site, please subscribe to our daily newsletter.